Search results
Results from the WOW.Com Content Network
The authorities also imported 2 million doses of vaccine from Sinovac, a Chinese company which Thai conglomerate Charoen Pokphand invested in, [7] during February to April 2021. [8] Likewise, the Thai government also stepped up its attempt to produce its homegrown vaccines amidst criticism, [9] with "ChulaCov19" and set to begin trials in May ...
A leaked health ministry document has prompted calls in Thailand for medical staff inoculated against COVID-19 to be given a booster of an mRNA vaccine, after it included a comment that such a ...
The COVID-19 pandemic in Southeast Asia is part of the ongoing worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was confirmed to have spread to Southeast Asia on 13 January 2020, when a 61-year-old woman from Wuhan tested positive in Thailand , making it the ...
The Thai king's sister has approved coronavirus vaccine imports by an institution she sponsors, bypassing the government as it deals with surging infections and growing public anger over a slow ...
Thai Prime Minister Prayuth Chan-ocha became the first person to be inoculated with the AstraZeneca COVID-19 vaccine in the Southeast Asian country on Tuesday after the rollout had been ...
Media coverage of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic. [1] [2] [3] The media also reported on various websites documenting such deaths, with some outlets questioning whether this practice was overly unsympathetic.
A preventive measure introduced in May; Thai Chana QR-code before entering a retail premise to track individual customers On 12 January, the World Health Organization (WHO) confirmed that a novel coronavirus was the cause of a respiratory illness in a cluster of people in Wuhan, Hubei, China, who had initially come to the attention of the WHO on 31 December 2019.
The S&P 500 erased earlier gains and turned slightly negative after a report emerged that Pfizer was contending with supply-chain issues that would impact this year’s deliveries of its COVID-19 ...